Why the Work of Dr. Nancy J. Sullivan Could Be Key to a Potential Ebola Vaccine
The Wall Street Journal
By Thomas M. Burton
BETHESDA, Md.—The world had little interest in Ebola in 1997, which is why cell biologist Nancy J. Sullivan thought she might be able to make a mark. Today, if the scientific world is to have an answer to the world’s severest Ebola outbreak, Dr. Sullivan’s work is likely to be at its center.
A senior investigator at the National Institutes of Health’s Vaccine Research Center, Dr. Sullivan has worked for years on a vaccine that has been proven to block Ebola in research monkeys. NIH is now racing to telescope what would have been a five- to 10-year testing plan into a few months. The vaccine is scheduled to undergo full human testing by early 2015 and could be in use potentially in time to help stem the disease in stricken West Africa.
Click here to read the full story.